Steven D Chang

Prof. Steven D Chang


Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 January 2019 in Nature Reviews Disease Primers
Verified
Journal Article
Closed access
PDF file
AAAchal Singh Achrol
Achal Singh Achrol
RRRobert C. Rennert
Robert C. Rennert
CACarey Anders
Carey Anders
Riccardo SoffiettiRiccardo Soffietti
Riccardo Soffietti
MAManmeet S. Ahluwalia
Manmeet S. Ahluwalia
SCSteven D Chang
Steven D Chang

1 June 2005 in Neurosurgery
Verified
Journal Article
Closed access
PDF file
SCSteven D Chang
Steven D Chang
IGIris C. Gibbs
Iris C. Gibbs
GSGordon T. Sakamoto
Gordon T. Sakamoto
ELElizabeth Lee
Elizabeth Lee
AOAdetokunbo Oyelese
Adetokunbo Oyelese
JAJohn R. Adler
John R. Adler
OBJECTIVE: Stereotactic radiosurgery has proven effective in the treatment of acoustic neuromas. Prior reports using single-stage radiosurgery consistently have shown excellent tumor control, but only up to a 50 to 73% likelihood of maintaining hearing at pretreatment levels. Staged, frame-based radiosurgery using 12-hour interfraction intervals previously has been shown by our group to achieve excellent tumor control while increasing the rate of hearing preservation at 2 years to 77%. The arrival of CyberKnife (Accuray, Inc., Sunnyvale, CA) image-guided radiosurgery now makes it more practical to treat acoustic neuroma with a staged approach. We hypothesize that such factors may further minimize injury of adjacent cranial nerves. In this retrospective study, we report our experience with staged radiosurgery for managing acoustic neuromas.METHODS: Since 1999, the CyberKnife has been used to treat more than 270 patients with acoustic neuroma at Stanford University. Sixty-one of these patients have now been followed up for a minimum of 36 months and form the basis for the present clinical investigation. Among the treated patients, the mean transverse tumor diameter was 18.5 mm, whereas the total marginal dose was either 18 or 21 Gy using three 6- or 7-Gy fractions. Audiograms and magnetic resonance imaging were obtained at 6-months intervals after treatment for the first 2 years and then annually thereafter.RESULTS: Of the 61 patients with a minimum of 36 months of follow-up (mean, 48 mo), 74% of patients with serviceable hearing (Gardner-Robinson Class 1–2) maintained serviceable hearing at the last follow-up, and no patient with at least some hearing before treatment lost all hearing on the treated side. Only one treated tumor (2%) progressed after radiosurgery; 29 (48%) of 61 decreased in size and 31 (50%) of the 61 tumors were stable. In no patients did new trigeminal dysfunction develop, nor did any patient experience permanent injury to their facial nerve; two patients experienced transient facial twitching that resolved in 3 to 5 months.CONCLUSION: Although still preliminary, these results indicate that improved tumor dose homogeneity and a staged treatment regimen may improve hearing preservation in acoustic neuroma patients undergoing stereotactic radiosurgery.

1 January 2003 in Neurosurgery
Verified
Journal Article
Closed access
SCSteven D Chang
Steven D Chang
WMWilliam Main
William Main
DMDavid P. Martin
David P. Martin
IGIris C. Gibbs
Iris C. Gibbs
MHM. Peter Heilbrun
M. Peter Heilbrun
Neurosurgery, the official journal of the Congress of Neurological Surgeons publishes research on clinical and experimental neurosurgery covering the very lates

Verified
Journal Article
Open access
PDF file
QCQiLiang Chen
QiLiang Chen
DYDae Ik Yi
Dae Ik Yi
JPJosiah Nathan Joco Perez
Josiah Nathan Joco Perez
MLMonica Liu
Monica Liu
SCSteven D Chang
Steven D Chang
XQXiang Qian
Xiang Qian
Trigeminal neuralgia (TN) is a complex orofacial pain syndrome characterized by the paroxysmal onset of pain attacks in the trigeminal distribution. The underlying mechanism for this debilitating condition is still not clearly understood. Decades of basic and clinical evidence support the demyelination hypothesis, where demyelination along the trigeminal afferent pathway is a major driver for TN pathogenesis and pathophysiology. Such pathological demyelination can be triggered by physical compression of the trigeminal ganglion or another primary demyelinating disease, such as multiple sclerosis. Further examination of TN patients and animal models has revealed significant molecular changes, channelopathies, and electrophysiological abnormalities in the affected trigeminal nerve. Interestingly, recent electrophysiological recordings and advanced functional neuroimaging data have shed new light on the global structural changes and the altered connectivity in the central pain-related circuits in TN patients. The current article aims to review the latest findings on the pathophysiology of TN and cross-examining them with the current surgical and pharmacologic management for TN patients. Understanding the underlying biology of TN could help scientists and clinicians to identify novel targets and improve treatments for this complex, debilitating disease.

1 July 2009 in Neurosurgery
Verified
Journal Article
Closed access
PDF file
JMJason M. Moss
Jason M. Moss
CCClara Y.H. Choi
Clara Y.H. Choi
JAJohn R. Adler
John R. Adler
SSScott G. Soltys
Scott G. Soltys
IGIris C. Gibbs
Iris C. Gibbs
SCSteven D Chang
Steven D Chang
OBJECTIVE. Stereotactic radiosurgery has been used for nearly 2 decades to treat hemangioblastomas, particularly those that are in surgically inaccessib

1 December 2011 in Neurosurgery
Verified
Journal Article
Closed access
PDF file
AHAke Hansasuta
Ake Hansasuta
CCClara Y. H. Choi
Clara Y. H. Choi
IGIris C. Gibbs
Iris C. Gibbs
SSScott G. Soltys
Scott G. Soltys
VTVictor C. K. Tse
Victor C. K. Tse
SCSteven D Chang
Steven D Chang
BACKGROUND. Single-session stereotactic radiosurgery (SRS) treatment of vestibular schwannomas results in excellent tumor control. It is not known wheth